Aspirin counseling
This article was originally published in The Tan Sheet
Executive Summary
AMA adopts a policy to increase physician education on the importance of appropriately counseling patients on aspirin therapy for prevention of heart disease and stroke, according to a separate release from the associations' annual meeting in Chicago. Six trials involving more than 95,000 adults using aspirin demonstrate the potential cardiovascular benefits of aspirin. Trial results show a 17 percent reduced risk of stroke in women and a 32 percent reduced risk of myocardial infarction in men (1"The Tan Sheet" Jan. 23, 2006, p. 7)...
You may also be interested in...
Aspirin Therapy Lowers Stroke Risk In Women, MI Risk In Men – JAMA
A recent meta-analysis identifying aspirin's cardiovascular benefits as gender-specific may demonstrate that primary prevention benefits extend to low-risk groups
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.